Jason Hughes , Joshua Stuart-Bennett , Michael Dunning , Hannah Farrimond
{"title":"Towards a dynamic processual model of psychedelic microdosing","authors":"Jason Hughes , Joshua Stuart-Bennett , Michael Dunning , Hannah Farrimond","doi":"10.1016/j.drugpo.2024.104691","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Existing research highlights an increase in psychedelic microdosing, particularly for therapeutic purposes and as a means for self-enhancement. However, we know little about the different routes into and out of microdosing, particularly by those who do not consume other illicit substances, and of the processes involved in the development, maintenance, and cessation of practices.</div></div><div><h3>Methods</h3><div>Drawing upon a trans-national interview-based study of 23 participants actively microdosing (<em>n</em> = 19), about to start (<em>n</em> = 3), or who were past users (<em>n</em> = 1), we develop a phased-based analysis of different user pathways.</div></div><div><h3>Results</h3><div>We identify key phases as: ‘Awareness/Discovery’, where participants became aware of microdosing; ‘Research/Reframing’, where they researched access, techniques, and undertook ‘stigma work’ to reframe risks; ‘Access/Supply’ where they sought reliable and safe sources of psychedelics and cultivated attitudes/practices/substances for longer-term use; ‘Experimentation/Differentiation’ where participants altered dosing levels/schedules and, inter-relatedly, differentiated ‘effects’ and ‘benefits’; ‘Independence/Incorporation’ where they stabilised practices into patterns ‘right for them’; and ‘Expansion/Advocacy’ where microdosing was linked to greater inter- and intrapersonal ‘expansiveness’.</div></div><div><h3>Conclusions</h3><div>Pathways in and out of microdosing are multilinear and differentiated. Nonetheless, a dynamic processual approach helps highlight the overall structure of changes involved which, we find, can entail a shift towards greater temporal and relational ‘expansiveness’, greater independence, and more incorporated practices. These shifts necessitated considerable ‘work’ variously to negate stigma, maintain supply, determine dose, document shifts, and other kinds of material–symbolic ‘investment’. We also show the significance of processual/phased-based models beyond psychedelics to better understand drug-use journeys and temporalities which confound conventional dependency-focused paradigms.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"136 ","pages":"Article 104691"},"PeriodicalIF":4.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S095539592400375X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Existing research highlights an increase in psychedelic microdosing, particularly for therapeutic purposes and as a means for self-enhancement. However, we know little about the different routes into and out of microdosing, particularly by those who do not consume other illicit substances, and of the processes involved in the development, maintenance, and cessation of practices.
Methods
Drawing upon a trans-national interview-based study of 23 participants actively microdosing (n = 19), about to start (n = 3), or who were past users (n = 1), we develop a phased-based analysis of different user pathways.
Results
We identify key phases as: ‘Awareness/Discovery’, where participants became aware of microdosing; ‘Research/Reframing’, where they researched access, techniques, and undertook ‘stigma work’ to reframe risks; ‘Access/Supply’ where they sought reliable and safe sources of psychedelics and cultivated attitudes/practices/substances for longer-term use; ‘Experimentation/Differentiation’ where participants altered dosing levels/schedules and, inter-relatedly, differentiated ‘effects’ and ‘benefits’; ‘Independence/Incorporation’ where they stabilised practices into patterns ‘right for them’; and ‘Expansion/Advocacy’ where microdosing was linked to greater inter- and intrapersonal ‘expansiveness’.
Conclusions
Pathways in and out of microdosing are multilinear and differentiated. Nonetheless, a dynamic processual approach helps highlight the overall structure of changes involved which, we find, can entail a shift towards greater temporal and relational ‘expansiveness’, greater independence, and more incorporated practices. These shifts necessitated considerable ‘work’ variously to negate stigma, maintain supply, determine dose, document shifts, and other kinds of material–symbolic ‘investment’. We also show the significance of processual/phased-based models beyond psychedelics to better understand drug-use journeys and temporalities which confound conventional dependency-focused paradigms.
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.